Immunogenic and tolerogenic cell death

Douglas R. Green; THOMAS FERGUSON; Laurence Zitvogel; Guido Kroemer

doi:10.1038/nri2545

journal article May 01, 2009

Immunogenic and tolerogenic cell death

Douglas R. Green

THOMAS FERGUSON

Laurence Zitvogel

Guido Kroemer

Nature Reviews Immunology Vol. 9 No. 5 pp. 353-363 · Springer Science and Business Media LLC

View at Publisher Save 10.1038/nri2545

Topics

No keywords indexed for this article. Browse by subject →

References

124

[1]

Reed, J. C. Drug insight: cancer therapy strategies based on restoration of endogenous cell death mechanisms. Nature Clin. Pract. Oncol. 3, 388–398 (2006). 10.1038/ncponc0538

[2]

Medzhitov, R. & Janeway, C. A. Jr. Decoding the patterns of self and nonself by the innate immune system. Science 296, 298–300 (2002). 10.1126/science.1068883

[3]

Zitvogel, L. et al. Immune response against dying tumor cells. Adv. Immunol. 84, 131–179 (2004). 10.1016/s0065-2776(04)84004-5

[4]

Gaipl, U. S. et al. Clearance deficiency and systemic lupus erythematosus (SLE). J. Autoimmun. 28, 114–121 (2007). 10.1016/j.jaut.2007.02.005

[5]

Matzinger, P. The danger model: a renewed sense of self. Science 296, 301–305 (2002). 10.1126/science.1071059

[6]

Thompson, C. B. Apoptosis in the pathogenesis and treatment of disease. Science 267, 1456–1462 (1995). 10.1126/science.7878464

[7]

Casares, N. et al. Caspase-dependent immunogenicity of doxorubicin-induced tumor cell death. J. Exp. Med. 202, 1691–1701 (2005). 10.1084/jem.20050915

[8]

Calreticulin exposure dictates the immunogenicity of cancer cell death

Michel Obeid, Antoine Tesniere, François Ghiringhelli et al.

Nature Medicine 2007 10.1038/nm1523

[9]

Apoptosis: A Basic Biological Phenomenon with Wideranging Implications in Tissue Kinetics

J F R Kerr, A H Wyllie, A R Currie

British Journal of Cancer 1972 10.1038/bjc.1972.33

[10]

Griffith, T. S., Yu, X., Herndon, J. M., Green, D. R. & Ferguson, T. A. CD95-induced apoptosis of lymphocytes in an immune privileged site induces immunological tolerance. Immunity 5, 7–16 (1996). This is an early paper showing that apoptotic cells induce tolerance to associated antigens. 10.1016/s1074-7613(00)80305-2

[11]

Ferguson, T. A. et al. Uptake of apoptotic antigen-coupled cells by lymphoid dendritic cells and cross-priming of CD8+ T cells produce active immune unresponsiveness. J. Immunol. 168, 5589–5595 (2002). 10.4049/jimmunol.168.11.5589

[12]

Belz, G. T. et al. The CD8α+ dendritic cell is responsible for inducing peripheral self-tolerance to tissue-associated antigens. J. Exp. Med. 196, 1099–1104 (2002). References 11 and 12 show that CD8α+ DCs cross-present antigen on MHC class I molecules to induce tolerance. 10.1084/jem.20020861

[13]

Garza, K. M. et al. Role of antigen-presenting cells in mediating tolerance and autoimmunity. J. Exp. Med. 191, 2021–2027 (2000). 10.1084/jem.191.11.2021

[14]

Miyake, Y. et al. Critical role of macrophages in the marginal zone in the suppression of immune responses to apoptotic cell-associated antigens. J. Clin. Invest. 117, 2268–2278 (2007). 10.1172/jci31990

[15]

Albert, M. L., Jegathesan, M. & Darnell, R. B. Dendritic cell maturation is required for the cross-tolerization of CD8+ T cells. Nature Immunol. 2, 1010–1017 (2001). 10.1038/ni722

[16]

Heath, W. R., Kurts, C., Miller, J. F. & Carbone, F. R. Cross-tolerance: a pathway for inducing tolerance to peripheral tissue antigens. J. Exp. Med. 187, 1549–1553 (1998). 10.1084/jem.187.10.1549

[17]

Steinman, R. M., Turley, S., Mellman, I. & Inaba, K. The induction of tolerance by dendritic cells that have captured apoptotic cells. J. Exp. Med. 191, 411–416 (2000). This is an important early review on tolerance induction that is mediated by the uptake of apoptotic cells. 10.1084/jem.191.3.411

[18]

Battisto, J. R. & Bloom, B. R. Dual immunological unresponsiveness induced by cell membrane coupled hapten or antigen. Nature 212, 156–157 (1966). Pre-dating most relevant studies by decades, this work shows that injected cells can cause immune tolerance. 10.1038/212156a0

[19]

Conlon, P. J., Miller, S. D. & Claman, H. N. The induction of tolerance to DNFB contact sensitivity by using hapten-modified lymphoid cells. III. Effects of hapten concentration on the ability of MLS-disparate cells to induce rapid unresponsiveness. J. Immunol. 125, 807–813 (1980). 10.4049/jimmunol.125.2.807

[20]

Pincott, C. E. & Bainbridge, D. R. Studies on transplantation immunity. IV. Murine natural immunity to lymphoid cells in vivo. Eur. J. Immunol. 10, 250–257 (1980). 10.1002/eji.1830100406

[21]

Sun, E. et al. Allograft tolerance induced by donor apoptotic lymphocytes requires phagocytosis in the recipient. Cell Death Differ. 11, 1258–1264 (2004). 10.1038/sj.cdd.4401500

[22]

van Twuyver, E. et al. Pretransplantation blood transfusion revisited. N. Engl. J. Med. 325, 1210–1213 (1991). 10.1056/nejm199110243251704

[23]

Pradhan, S. et al. A critical role for the proapoptotic protein Bid in ultraviolet-induced immune suppression and cutaneous apoptosis. J. Immunol. 181, 3077–3088 (2008). 10.4049/jimmunol.181.5.3077

[24]

Schwarz, A. et al. Ultraviolet light-induced immune tolerance is mediated via the Fas/Fas-ligand system. J. Immunol. 160, 4262–4270 (1998). 10.4049/jimmunol.160.9.4262

[25]

Heath, W. R. & Carbone, F. R. Cross-presentation, dendritic cells, tolerance and immunity. Annu. Rev. Immunol. 19, 47–64 (2001). 10.1146/annurev.immunol.19.1.47

[26]

Steinman, R. M., Hawiger, D. & Nussenzweig, M. C. Tolerogenic dendritic cells. Annu. Rev. Immunol. 21, 685–711 (2003). 10.1146/annurev.immunol.21.120601.141040

[27]

Segal, N. H. et al. Epitope landscape in breast and colorectal cancer. Cancer Res. 68, 889–892 (2008). 10.1158/0008-5472.can-07-3095

[28]

Toll-like receptor 4–dependent contribution of the immune system to anticancer chemotherapy and radiotherapy

Lionel Apetoh, François Ghiringhelli, Antoine Tesniere et al.

Nature Medicine 2007 10.1038/nm1622

[29]

Zitvogel, L., Apetoh, L., Ghiringhelli, F. & Kroemer, G. Immunological aspects of cancer chemotherapy. Nature Rev. Immunol. 8, 59–73 (2008). 10.1038/nri2216

[30]

Johansson, U., Walther-Jallow, L., Smed-Sorensen, A. & Spetz, A. L. Triggering of dendritic cell responses after exposure to activated, but not resting, apoptotic PBMCs. J. Immunol. 179, 1711–1720 (2007). 10.4049/jimmunol.179.3.1711

[31]

Herndon, J. M., Stuart, P. M. & Ferguson, T. A. Peripheral deletion of antigen-specific T cells leads to long-term tolerance mediated by CD8+ cytotoxic cells. J. Immunol. 174, 4098–4104 (2005). 10.4049/jimmunol.174.7.4098

[32]

The DNA damage pathway regulates innate immune system ligands of the NKG2D receptor

Stephan Gasser, Sandra Orsulic, Eric J. Brown et al.

Nature 2005 10.1038/nature03884

[33]

Wajapeyee, N., Serra, R. W., Zhu, X., Mahalingam, M. & Green, M. R. Oncogenic BRAF induces senescence and apoptosis through pathways mediated by the secreted protein IGFBP7. Cell 132, 363–374 (2008). 10.1016/j.cell.2007.12.032

[34]

Kuilman, T. et al. Oncogene-induced senescence relayed by an interleukin-dependent inflammatory network. Cell 133, 1019–1031 (2008). 10.1016/j.cell.2008.03.039

[35]

Acosta, J. C. et al. Chemokine signaling via the CXCR2 receptor reinforces senescence. Cell 133, 1006–1018 (2008). 10.1016/j.cell.2008.03.038

[36]

Xue, W. et al. Senescence and tumour clearance is triggered by p53 restoration in murine liver carcinomas. Nature 445, 656–660 (2007). An interesting study in which induction of cellular senescence triggers immune-mediated tumour cell clearance. 10.1038/nature05529

[37]

Srivastava, P. K. Therapeutic cancer vaccines. Curr. Opin. Immunol. 18, 201–205 (2006). 10.1016/j.coi.2006.01.009

[38]

Obeid, M. et al. Ecto-calreticulin in immunogenic chemotherapy. Immunol. Rev. 220, 22–34 (2007). 10.1111/j.1600-065x.2007.00567.x

[39]

Spisek, R. et al. Bortezomib enhances dendritic cell (DC)-mediated induction of immunity to human myeloma via exposure of cell surface heat shock protein 90 on dying tumor cells: therapeutic implications. Blood 109, 4839–4845 (2007). 10.1182/blood-2006-10-054221

[40]

Panaretakis, T. et al. The co-translocation of ERp57 and calreticulin determines the immunogenicity of cell death. Cell Death Differ. 15, 1499–1509 (2008). 10.1038/cdd.2008.67

[41]

Lauber, K. et al. Apoptotic cells induce migration of phagocytes via caspase-3-mediated release of a lipid attraction signal. Cell 113, 717–730 (2003). 10.1016/s0092-8674(03)00422-7

[42]

Le, L. Q. et al. Mice lacking the orphan G protein-coupled receptor G2A develop a late-onset autoimmune syndrome. Immunity 14, 561–571 (2001). 10.1016/s1074-7613(01)00145-5

[43]

Peter, C. et al. Migration to apoptotic “find-me” signals is mediated via the phagocyte receptor G2A. J. Biol. Chem. 283, 5296–5305 (2008). 10.1074/jbc.m706586200

[44]

Koizumi, S. et al. UDP acting at P2Y6 receptors is a mediator of microglial phagocytosis. Nature 446, 1091–1095 (2007). 10.1038/nature05704

[45]

Hanley, P. J. et al. Extracellular ATP induces oscillations of intracellular Ca2+ and membrane potential and promotes transcription of IL-6 in macrophages. Proc. Natl Acad. Sci. USA 101, 9479–9484 (2004). 10.1073/pnas.0400733101

[46]

Gout-associated uric acid crystals activate the NALP3 inflammasome

Fabio Martinon, Virginie Pétrilli, Annick Mayor et al.

Nature 2006 10.1038/nature04516

[47]

Martinon, F., Gaide, O., Petrilli, V., Mayor, A. & Tschopp, J. NALP inflammasomes: a central role in innate immunity. Semin. Immunopathol. 29, 213–229 (2007). 10.1007/s00281-007-0079-y

[48]

Scaffidi, P., Misteli, T. & Bianchi, M. E. Release of chromatin protein HMGB1 by necrotic cells triggers inflammation. Nature 418, 191–195 (2002). This is a key study that identifies HMGB1 as a DAMP. 10.1038/nature00858

[49]

Bell, C. W., Jiang, W., Reich, C. F. 3rd & Pisetsky, D. S. The extracellular release of HMGB1 during apoptotic cell death. Am. J. Physiol. Cell Physiol. 291, C1318–C1325 (2006). 10.1152/ajpcell.00616.2005

[50]

The Relationship between Apoptosis and High-Mobility Group Protein 1 Release from Murine Macrophages Stimulated with Lipopolysaccharide or Polyinosinic-Polycytidylic Acid

Weiwen Jiang, Charles W Bell, David S Pisetsky

The Journal of Immunology 2007 10.4049/jimmunol.178.10.6495

Showing 50 of 124 references

Cited By

980

Interference of ATP‐Adenosine Axis by Engineered Biohybrid for Amplifying Immunogenic Cell Death‐Mediated Antitumor Immunotherapy

Xin‐Chen Deng, Jun‐Long Liang · 2024

Advanced Materials

Current status of nanoparticle-mediated immunogenic cell death in cancer immunotherapy

Tuan Hiep Tran, Thi Thu Phuong Tran · 2024

International Immunopharmacology

Control of Cell Death in Health and Disease

Nobuhiko Kayagaki, Joshua D. Webster · 2024

Annual Review of Pathology: Mechani...

Cell death, therapeutics, and the immune response in cancer

Kay Hänggi, Brian Ruffell · 2023

Trends in Cancer

Nanoscale Covalent Organic Framework with Staggered Stacking of Phthalocyanines for Mitochondria-Targeted Photodynamic Therapy

Jing Liu, Dong Won Kang · 2023

Journal of the American Chemical So...

Autophagy Impairment through Lysosome Dysfunction by Brucine Induces Immunogenic Cell Death (ICD)

Nestor Ishimwe, Pengfei Wei · 2020

The American Journal of Chinese Med...

Consensus guidelines for the definition, detection and interpretation of immunogenic cell death

Lorenzo Galluzzi, Ilio Vitale · 2020

Journal for ImmunoTherapy of Cancer

Nanoparticle‐Mediated Immunogenic Cell Death Enables and Potentiates Cancer Immunotherapy

Xiaopin Duan, Christina Chan · 2018

Angewandte Chemie International Edi...

Heat shock proteins in the context of photodynamic therapy: autophagy, apoptosis and immunogenic cell death

Matías E. Rodríguez, Ingrid S. Cogno · 2016

Photochemical & Photobiological...

Molecular and Translational Classifications of DAMPs in Immunogenic Cell Death

Abhishek D. Garg, Lorenzo Galluzzi · 2015

Frontiers in Immunology

High hydrostatic pressure induces immunogenic cell death in human tumor cells

Jitka Fucikova, Irena Moserova · 2014

International Journal of Cancer

Metrics

980

Citations

124

References

Details

Published: May 01, 2009
Vol/Issue: 9(5)
Pages: 353-363
License: View

Authors

RENSSELAER POLYTECHNIC INSTITUTE

L

Laurence Zitvogel

4Gustave Roussy Cancer Campus (GRCC), Villejuif, France.; 5Institut National de la Santé Et de la Recherche Médicale (INSERM) U1015, Villejuif, France.; 6Univ. Paris-Sud, Université Paris-Saclay, Gustave Roussy, Villejuif, France.; 7Center of Clinical Investigations in Biotherapies of Cancer (CICBT) 1428, Villejuif, France.

G

Guido Kroemer

Cite This Article

Douglas R. Green, THOMAS FERGUSON, Laurence Zitvogel, et al. (2009). Immunogenic and tolerogenic cell death. Nature Reviews Immunology, 9(5), 353-363. https://doi.org/10.1038/nri2545

Immunogenic and tolerogenic cell death

You May Also Like